Related Experiment Video
Updated: Jun 5, 2026
05:36
Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
Published on: January 30, 2020
Remifentanil in critically ill cardiac patients
Laura Ruggeri1, Giovanni Landoni, Fabio Guarracino
1Department of Anesthesia and Intensive Care Medicine, Università Vita-Salute San Raffaele, Milan, Italy.
Annals of Cardiac Anaesthesia
|January 4, 2011
Summary
Remifentanil offers rapid action and metabolism, making it suitable for critically ill cardiac patients, even with organ dysfunction. Its benefits include improved recovery and reduced ventilation time, with comparable side effects to other opioids.
Area of Science:
- Anesthesiology
- Pharmacology
- Cardiology
Background:
- Remifentanil possesses a unique pharmacokinetic profile characterized by rapid onset and offset of action.
- Its metabolism occurs in plasma, allowing for its use in patients with renal or hepatic impairment.
- A potential cardiac preconditioning effect has been suggested for remifentanil.
Purpose of the Study:
- To review the benefits and applications of remifentanil in cardiac surgery and intensive care settings.
- To highlight remifentanil's suitability for patients with organ dysfunction.
- To assess the safety and efficacy of remifentanil in various cardiac procedures.
Main Methods:
- Review of randomized controlled trials and clinical data on remifentanil use.
- Analysis of pharmacokinetic and pharmacodynamic properties.
- Evaluation of adverse effects and clinical outcomes.
Main Results:
- Remifentanil provides protection against intraoperative stress, facilitates rapid postoperative recovery, and enables early extubation.
- It is well-suited for minimally invasive cardiologic procedures and diagnostic interventions.
- In intensive care units, remifentanil reduces time to tracheal extubation and offers advantages in organ-dysfunctional patients.
Conclusions:
- Remifentanil's unique properties make it a valuable agent for critically ill cardiac patients.
- Its safety profile is comparable to other opioids, with potential benefits in organ dysfunction.
- Remifentanil is expected to play a significant role in the management of cardiac patients.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...